Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

$480B in new pandemic relief appears imminent for hospitals, small businesses

Pending votes on Capitol Hill, hospitals are soon to receive relief from pandemic economics in the form of a $480 billion-plus aid package agreed upon by Congressional leaders and the White House late Tuesday afternoon.

Thumbnail

Rural hospitals closing as pandemic crisis continues

If three or more significant and similar occurrences signify a trend, the U.S. hospitals that have closed in the heat of the COVID-19 crisis—mostly rural institutions—may be harbingers of things to come.

Thumbnail

AI expert builds COVID-19 prediction model for smaller cities

With so many eyes fixed on New York City as the “epicenter” of the COVID-19 crisis in the U.S., it might go unnoticed at the national level that nearly 60,000 infections could be recorded some 150 miles to the north by June 8.

Thumbnail

Antivaxxers finding allies in more than a few chiropractors

At a time when mandatory immunization bills are pending in numerous states, more than enough chiropractors have organized against the norm to raise many eyebrows and considerable Cain.

Thumbnail

AI specialists raise $9M to expand platform for reducing medical errors

Ferrum Health, a San Francisco-based healthcare technology company, has closed a funding round worth $9 million.

Thumbnail

13-state hospital operator expected to file for bankruptcy

A health system that runs 23 hospitals has moved to restructure its debt, a move that will likely lead to its filing for Chapter 11 protection.

Thumbnail

Microsoft exec raised in Appalachia calls US healthcare to help ‘make AI serve us all’

Microsoft CTO Kevin Scott surely didn’t see the coronavirus coming when he was writing his new book on AI. But with the title’s April 7 release, he’s perceiving the pandemic as equal parts threat and opportunity.

Thumbnail

Digital tool predicts COVID-19 supply/demand stresses in each state

Any interested party can now see state-by-state forecasts for peak hospitalization vs. capacity due to COVID-19 over the coming four months.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.